SRPT
Sarepta Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$22.50
−2.13%Forward multiples
Based on analyst estimates
- P/E forward
- 39.14x
- P/E 2026E
- 6.80x
- P/E 2027E
- 29.66x
- P/E 2028E
- 46.15x
- P/S forward
- 1.68x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.56x
- Price / sales
- 1.20x
- Price / cash flow
- -25.92x
Enterprise value
- Enterprise value
- $2.6B
- EV / sales
- 1.33x
- EV / EBITDA
- -180.61x
- EV / EBIT
- -18.39x
- Market cap
- $2.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026